You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CORT Sale Disclosure
Mokari Atabak · SEC Form 4 · Filed Jul 17, 2026
Sale
Calculated transaction value
$687.18K
Mokari Atabak Chief Financial Officer
CORT
Transaction date
Jul 15, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 2 days later
CORT daily price context
Close on/before transaction
$89.57
Jul 15, 2026
First close after public filing
$91.57
Jul 20, 2026
30-day return after filing
+27.96%
Through Aug 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,919 shares @ $86.78
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-308058
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$4.37M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Corcept Therapeutics Inc CORT | Exercise | Jul 15, 2026 | $304.94K |
| Corcept Therapeutics Inc CORT | Exercise | Jul 15, 2026 | $557.29K |
| Corcept Therapeutics Inc CORT Current | Sale | Jul 15, 2026 | $687.18K |
| Corcept Therapeutics Inc CORT | Sale | Jul 15, 2026 | $2.5M |
| Corcept Therapeutics Inc CORT | Sale | Jul 15, 2026 | $310.82K |
| Corcept Therapeutics Inc CORT | Sale | Jul 15, 2026 | $9.03K |
| Corcept Therapeutics Inc CORT | Exercise | Jul 15, 2026 | $0 |
| Corcept Therapeutics Inc CORT | Exercise | Jul 15, 2026 | $0 |